equityflowunderstand the flow and follow it

EquityFlow › Companies › Nanoligent

Nanoligent

Biotech · Barcelona, ES

Develops targeted nanodrugs for cancer treatment.

In the network

Shares the most investors with (number = shared investors):

Funding history

Date	Round	Amount
Oct 2025	Funding round Nanoligent raised €12 million led by Inveready for its precision oncology nanodrugs.	$13.9M

Investors

Tap an investor to see what else they have backed.

CDTI Clave Capital Inveready

Other companies in Biotech

Imperagen Haga Bioscience Pixelgen Technologies Gallant Chai Discovery SNIPR Biome Cellbox Labs Scope Biosciences GenLumina Actithera NUCLIDIUM Anocca

Other companies in ES

Theker Factorial Mafer AI Zazume Modelia Altano Energy TuringDream Multiverse Computing Aortyx Biorce QualiBooth Tether Energy

Other companies at Unknown stage

&Charge /dev/agents 123-Transporter 123fahrschule 13Hz 1Global 1Komma5°1MT Nation 1Password 20Face 21.co 2NA FISH

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.